Document is current
Any future updates will be listed below
-
Authors
Mao, Xiangyun
Wang, Zhaoqing
Kong, Shu
Yang, Yue
Dreyer, Nancy A. https://orcid.org/0000-0003-0153-8286
Ba, Yi https://orcid.org/0000-0003-0255-4376
Lotze, Michael T.
Zhan, Qimin https://orcid.org/0000-0002-1731-938X
Li, Guanqiao https://orcid.org/0000-0002-3626-7220
-
Funding
Funding for this research was provided by:
Beijing Nova Program
National Natural Science Foundation of China (72374119)
- License Information
-
More Information
Article History
Received: 20 November 2024
Revised: 4 September 2025
Accepted: 16 January 2026
First Online: 11 May 2026
Competing interests
: M.T.L. is a member of the Scientific Advisory Boards of KSQ, Inc., BioCytics, Zai Laboratories, Appel Sauce Studios, Zola Therapeutics, and the Ludwig Institute. Q.Z. is the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling. Other authors declare no competing interests.
